Cancer Gene Therapy
Research conducted at Nanjing Medical University has provided new information about cancer gene therapy
Published in Gene Therapy Weekly, January 25th, 2007
New investigation results, "Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells," are detailed in a study published in Auris Nasus Larynx. According to recent research from Nanjing, People's Republic of China, "Adoptive immunotherapy with specific cytotoxicity T lymphocytes (CTLs) induced by dendritic cells (DCs) pulsed with tumor antigens plays a crucial role in the immunity against tumor. The purpose of this study was to assess the feasibility and efficacy of latent membrane protein 2A (LMP2A)-specific CTLs immunity against nasopharyngeal carcinoma (NPC) in vitro and in vivo."
"DCs were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-01-25)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Data from Shanghai Jiao Tong University, Department of Gastroenterology advance knowledge in cancer gene therapy - Cancer Gene Therapy
Data on cancer gene therapy detailed by researchers at National Institutes of Health - Cancer Gene Therapy
Reports on cancer gene therapy findings from Washington University provide new insights - Cancer Gene Therapy
Research data from Korea Institute of Radiological and Medical Science update understanding of cancer gene therapy - Cancer Gene Therapy
Researchers from Lombardi Comprehensive Cancer Center, Department of Radiation Medicine detail findings in cancer gene therapy - Cancer Gene Therapy
Researchers from University of Minnesota, Cancer Center discuss findings in cancer gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
